Article Summary

This article tells the story of a powerful new HIV prevention drug, lenacapavir, that can protect people for six months with just one injection, focusing on its success in a trial in Uganda where participants like a young woman named Irene gained life-changing protection. It highlights the drug's effectiveness and the emotional impact on those at risk, while also pointing to delays in making it widely available due to funding and government inaction. The article uses strong, hopeful language and personal stories to build urgency around getting this drug to more people, especially in poor countries.